We highly recommend enabling Javascript while using the BlackBoxRX site.


All Cause Mortality

  • All-cause mortality was higher in patients treated with tigecycline than comparators in a meta-analysis of clinical trials. The cause of this mortality risk difference of 0.6% (95% CI 0.1, 1.2) has not been established. Tigecycline for injection should be reserved for use in situations when alternative treatments are not suitable.

FDA and Industry Communications

Index to FDA Drug Safety Information

Patient Counseling Information

Package Inserts


Updated September 2018